Therapeutic Areas

Endocrine and Metabolic Disease Full-Service CRO & Consultancy

Overcoming complexities to advance your endocrine and metabolic disease treatments to market rapidly

Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy. At Veristat, we have assembled an extraordinary team of scientific-minded experts who have mastered the complexities of running metabolic disease trials. In the past five years, our team has supported 200+ projects for endocrine/metabolic disorder treatments and prepared 20+ marketing applications. 

Developing endocrine or metabolic therapy?   Let’s Talk.  

Endocrine and Metabolic Disease Experience in the Past 5 Years


clinical trials & consulting project supported


in Rare/Ultra-Rare Indications


are Biologic therapies

Experience in Taking on Endocrine and Metabolic Disease Clinical Trials

Whether you are aiming to combat a thyroid, inherited, or reproductive disorder, Veristat can help make a difference in your study’s success. Our teams understand the nuances and difficulties involved with treating endocrine and metabolic diseases, including experience executing type 1 and 2 diabetes trials. 

Veristat’s experts are poised to plan and launch your trials quickly providing: 


HubDB_Card Image_Flexibility Drives Progress


Case Study: Flexibility Drives Progress During a Rare Disease Gene Therapy Clinical Trial 

Veristat was engaged by a biotech organization focusing on gene therapies for metabolic diseases to support their clinical study for the treatment of a rare human genetic lysosomal storage disorder. Through a collaborative partnership and a flexible operating model, we addressed critical patient, lab, product manufacturing, logistics, and tracking/reporting requirements to satisfy our Sponsor’s requirements at every milestone.   

Read Case Study 

Scientific Excellence Across Endocrine & Metabolic Disease Indications 

Common Indications

  • Anorexia 
    Diabetes (Type 1 and 2) 
    Polycystic Ovary Syndrome 
    and more...

Common Endocrine and Metabolic Disease Indications

Rare Indications

  • Adrenoleukodystrophy 
    Bardet-Biedl Syndrome 
    Fabry Disease 
    Gaucher Disease 
    Lysosomal Acid Lipase Deficiency 
    Pompe Disease 
    and many more... 
rare endocrine metabolic disease indications

Pediatric Indications

  • Achondroplasia 
  • Cerebral Adrenoleukodystrophy  
  • Duchenne Muscular Dystrophy 
  • Limb-girdle Muscular Dystrophy 
  • Myotonic Dystrophy 
  • and more...
pediatric endocrine metabolic disease indications
I would like to thank the entire team at Veristat, who worked day and night to submit our DSUR and our IND within thirty days of starting to work with us!

In addition to managing the process, the team worked seamlessly with us in the United States and our partner in Korea. Your team advised and guided us to produce quality submissions to meet our challenging corporate goal of submitting both on time. Due to these extraordinary efforts, we plan to work with you on our second IND submission.
Clinical Stage Biotechnology Company

Find out how our clinical trial and regulatory experts can help with your next study or program.


Learn More with These Resources

Case Study

Advancing to Your Next Milestone – Global Regulatory ...

Fact Sheet

Veristat Corporate Fact Sheet

Case Study

Pursuing Breakthrough Therapies for Rare Metabolic Diseases